Ionis Pharmaceuticals Inc SEC filings IONS

Ionis Pharmaceuticals Inc has 1,005 filings in SEC EDGAR's recent list, going back to Jul 6, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Ionis Pharmaceuticals Inc SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 5, 2025
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 6, 2024
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —
DEFA14A Additional proxy material Apr 20, 2022 —
DEF 14A Proxy statement Apr 20, 2022 Jun 2, 2022
DEFA14A Additional proxy material May 20, 2021 —
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 2, 2021

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IONS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
Carlsbad, CA
SEC filer status
Large accelerated filer
SEC CIK
874015
Former names
ISIS PHARMACEUTICALS INC (until Dec 18, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.